Study S002471
Transform CV Risk in Diabetes
Registration
Registered primary outcomes
- New prescription of a SGLT2i and/or GLP-1RA [9 months]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.